Magnolia Medical Technologies is a Washington-state medical manufacturing company that makes biopharma products. Its lobbying filings show it spends on federal issues tied to Medicare and Medicaid, especially hospital inpatient quality programs and the Inpatient Prospective Payment System (IPPS) proposed rule. It also lobbied on H.R. 5275, the Diagnostic Accuracy in Sepsis Act, and on Labor-HHS-Education appropriations.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
KATHLEEN LESTER
The latest disclosures for this client.
LESTER HEALTH LAW PLLC
3ALESTER HEALTH LAW PLLC
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
LESTER HEALTH LAW PLLC
LESTER HEALTH LAW PLLC
Q2LESTER HEALTH LAW PLLC
Q1LESTER HEALTH LAW PLLC
Q4LESTER HEALTH LAW PLLC
Q3LESTER HEALTH LAW PLLC
Q2LESTER HEALTH LAW PLLC
Q1